Lonza to Boost Biologics Sales With Manufacturing Facility Buy

Mar 20, 2024 | Uncategorized

Lonza agreed to buy a manufacturing facility in the U.S. from Roche for around $1.2 billion in cash as it seeks to grow its biologics division.

Translate »
Contactar
1
Scan the code
Hola👋
¿Cómo podemos ayudarte?